Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
boston blog main
boston top stories
clinical trials
3
×
depression
3
×
life sciences
national blog main
3
×
national top stories
new york blog main
new york top stories
biotech
blackstone group
boston
david goldstein
epilepsy
essential tremor
fda
kiran reddy
major depressive disorder
perimenopausal depression
praxis precision medicines
san francisco blog main
san francisco top stories
steven petrou
alector
aligos therapeutics
alkermes
antisense oligonucleotide
avrobio
baker brothers life sciences
baricitinib
bcma
benzodiazepine
benzodiazepines
biogen
biotech ipos
blackstone life sciences
blepharitis
bolt biotherapeutics
boulder/denver blog main
boulder/denver top stories
What
drugs
medicines
new
praxis
precision
research
aims
backed
bio
biopharma
biotechs
cause
central
ceo
cns
congress
congressional
crispr
disorder
emerged
epilepsy
executives
feud
genes
genetic
group
ipos
isn’t
kept
known
later
leads
links
marcio
month
mutations
nervous
neuro
ny
pharma
Language
unset
Current search:
depression
×
photo
×
" national blog main "
×
" clinical trials "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More